These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25266426)

  • 1. Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.
    Yin DE; Warshaw MG; Miller WC; Castro H; Fiscus SA; Harper LM; Harrison LJ; Klein NJ; Lewis J; Melvin AJ; Tudor-Williams G; McKinney RE;
    Pediatrics; 2014 Oct; 134(4):e1104-16. PubMed ID: 25266426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting.
    Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Dyke RB; Seage GR;
    Clin Infect Dis; 2008 Jun; 46(11):1751-60. PubMed ID: 18426371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
    Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
    Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic function and virologic suppression among children with perinatally acquired HIV Infection on highly active antiretroviral therapy.
    Rutstein RM; Gebo KA; Flynn PM; Fleishman JA; Sharp VL; Siberry GK; Spector SA
    Med Care; 2005 Sep; 43(9 Suppl):III15-22. PubMed ID: 16116305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune status.
    van Rossum AM; Scherpbier HJ; van Lochem EG; Pakker NG; Slieker WA; Wolthers KC; Roos MT; Kuijpers JH; Hooijkaas H; Hartwig NG; Geelen SP; Wolfs TF; Lange JM; Miedema F; de Groot R;
    AIDS; 2001 Nov; 15(17):2267-75. PubMed ID: 11698700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy.
    Puthanakit T; Kerr S; Ananworanich J; Bunupuradah T; Boonrak P; Sirisanthana V
    Pediatr Infect Dis J; 2009 Jun; 28(6):488-92. PubMed ID: 19504731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of the CD4 T cell compartment after long-term highly active antiretroviral therapy without phenotypical signs of accelerated immunological aging.
    Vrisekoop N; van Gent R; de Boer AB; Otto SA; Borleffs JC; Steingrover R; Prins JM; Kuijpers TW; Wolfs TF; Geelen SP; Vulto I; Lansdorp P; Tesselaar K; Borghans JA; Miedema F
    J Immunol; 2008 Jul; 181(2):1573-81. PubMed ID: 18606713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.
    Hecht FM; Wang L; Collier A; Little S; Markowitz M; Margolick J; Kilby JM; Daar E; Conway B; Holte S;
    J Infect Dis; 2006 Sep; 194(6):725-33. PubMed ID: 16941337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low immunologic response to highly active antiretroviral therapy in naive vertically human immunodeficiency virus type 1-infected children with severe immunodeficiency.
    Resino S; Alvaro-Meca A; de José MI; Martin-Fontelos P; Gutiérrez MD; Léon JA; Ramos JT; Ciria L; Muñoz-Fernández MA
    Pediatr Infect Dis J; 2006 Apr; 25(4):365-8. PubMed ID: 16567992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune reconstitution in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy: a cohort study.
    Johnston AM; Valentine ME; Ottinger J; Baydo R; Gryszowka V; Vavro C; Weinhold K; St Clair M; McKinney RE
    Pediatr Infect Dis J; 2001 Oct; 20(10):941-6. PubMed ID: 11642627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive effects of body mass index on immune reconstitution among HIV-infected HAART users in China.
    Li X; Ding H; Geng W; Liu J; Jiang Y; Xu J; Zhang Z; Shang H
    BMC Infect Dis; 2019 May; 19(1):373. PubMed ID: 31046702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study.
    Walker AS; Doerholt K; Sharland M; Gibb DM;
    AIDS; 2004 Sep; 18(14):1915-24. PubMed ID: 15353977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Early Versus Late Antiretroviral Treatment Initiation on Naive T Lymphocytes in HIV-1-Infected Children and Adolescents - The-ANRS-EP59-CLEAC Study.
    Frange P; Montange T; Le Chenadec J; Batalie D; Fert I; Dollfus C; Faye A; Blanche S; Chacé A; Fourcade C; Hau I; Levine M; Mahlaoui N; Marcou V; Tabone MD; Veber F; Hoctin A; Wack T; Avettand-Fenoël V; Warszawski J; Buseyne F
    Front Immunol; 2021; 12():662894. PubMed ID: 33968064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-line protease inhibitor-based HAART after failing non-nucleoside reverse transcriptase inhibitor-based regimens in Asian HIV-infected children.
    Bunupuradah T; Puthanakit T; Fahey P; Kariminia A; Yusoff NK; Khanh TH; Sohn AH; Chokephaibulkit K; Lumbiganon P; Hansudewechakul R; Razali K; Kurniati N; Huy BV; Sudjaritruk T; Kumarasamy N; Fong SM; Saphonn V; Ananworanich J;
    Antivir Ther; 2013; 18(4):591-8. PubMed ID: 23296119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, Virologic, Immunologic Outcomes and Emerging HIV Drug Resistance Patterns in Children and Adolescents in Public ART Care in Zimbabwe.
    Makadzange AT; Higgins-Biddle M; Chimukangara B; Birri R; Gordon M; Mahlanza T; McHugh G; van Dijk JH; Bwakura-Dangarembizi M; Ndung'u T; Masimirembwa C; Phelps B; Amzel A; Ojikutu BO; Walker BD; Ndhlovu CE
    PLoS One; 2015; 10(12):e0144057. PubMed ID: 26658814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of HIV-infected children in Thailand: the Thailand Pediatric HIV Observational Database.
    Phongsamart W; Hansudewechakul R; Bunupuradah T; Klinbuayaem V; Teeraananchai S; Prasithsirikul W; Kerr SJ; Akarathum N; Denjunta S; Ananworanich J; Chokephaibulkit K
    Int J Infect Dis; 2014 May; 22():19-24. PubMed ID: 24576843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count.
    García F; de Lazzari E; Plana M; Castro P; Mestre G; Nomdedeu M; Fumero E; Martínez E; Mallolas J; Blanco JL; Miró JM; Pumarola T; Gallart T; Gatell JM
    J Acquir Immune Defic Syndr; 2004 Jun; 36(2):702-13. PubMed ID: 15167289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing immune reconstitution after long-term highly active antiretroviral therapy in pediatric AIDS.
    Resino S; Correa R; Bellón JM; Sánchez-Ramón S; Muñoz-Fernández MA
    AIDS Res Hum Retroviruses; 2002 Dec; 18(18):1395-406. PubMed ID: 12487811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of highly active antiretroviral therapy on nutritional and immunologic status in HIV-infected children in the low-income country of Ethiopia.
    Ebissa G; Deyessa N; Biadgilign S
    Nutrition; 2016 Jun; 32(6):667-73. PubMed ID: 26875999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.